ESR1 and breast cancer: That same study also noted that recombinant OSM potently suppressed the ER protein and mRNA expression in vitro and that loss of ER expression was necessary for OSM-mediated signal transduction and migratory effects in ER+ MCF7 and T47D breast cancer cells [55].